内蒙古地区糖尿病合并高血压患者可改变心血管危险因素的治疗与控制：横断面研究,Journal of Clinical Hypertension

当前位置： X-MOL 学术 › J. Clin. Hypertens. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

内蒙古地区糖尿病合并高血压患者可改变心血管危险因素的治疗与控制：横断面研究
Journal of Clinical Hypertension ( IF 2.7 ) Pub Date : 2021-10-26 , DOI: 10.1111/jch.14375
Yanqing Bi ₁ , Zixuan Tian ₁ , Wenyan Yan ₁ , Min Liu ₁ , Yuqian Zhao ₁ , Han Bao ₁ , Tao Yan ₁ , Nan Zhang ₁ , Yuan Xia ₁ , Xingguang Zhang ₁

Affiliation

作者评估了内蒙古糖尿病 (DM) 和高血压 (HTN) 患者的血糖、血压 (BP) 和血脂的治疗和控制情况，并确定了与治疗和实现血糖、血压 (BP) 相关的可改变因素和血脂目标。作者根据内蒙古的地理位置和经济发展水平，采用了多阶段分层整群抽样方法。在DM和HTN患者中，空腹血糖（FPG）治疗和控制的粗率分别为30.76%和4.73%。BP处理和对照的粗率分别为50.81%和8.70%。作者发现HTN和DM的治疗率和BP和FPG的控制率随着年龄的增加呈逐渐增加的趋势。在 DM 和 HTN 患者中，在年龄较大、非蒙古人、男性、肥胖、吸烟和既往患有心血管疾病的参与者中，治疗 HTN 和 DM 的可能性显着增加。作者发现，研究参与者对血压、FPG 和低密度脂蛋白胆固醇的控制远非最佳。内蒙古医疗卫生部门应采取适当措施减轻人群糖尿病和高血压的负担，如通过促进和提高高血压和糖尿病的治疗质量，达到控制目标，降低心血管疾病风险。研究参与者的低密度脂蛋白胆固醇远非最佳。内蒙古医疗卫生部门应采取适当措施减轻人群糖尿病和高血压的负担，如通过促进和提高高血压和糖尿病的治疗质量，实现控制目标，降低心血管疾病风险。研究参与者的低密度脂蛋白胆固醇远非最佳。内蒙古医疗卫生部门应采取适当措施减轻人群糖尿病和高血压的负担，如通过促进和提高高血压和糖尿病的治疗质量，实现控制目标，降低心血管疾病风险。

"点击查看英文标题和摘要"

Treatment and control of modifiable cardiovascular risk factors among patients with diabetes mellitus and hypertension in Inner Mongolia: A cross-sectional study

The authors assessed treatment and control of blood glucose, blood pressure (BP), and blood lipids among patients from Inner Mongolia with diabetes mellitus (DM) and hypertension (HTN) and identified the modifiable factors associated with treatment and achievement of blood glucose, BP, and blood lipid targets. The authors used a multistage stratified cluster sampling method according to geographical location and level of economic development in Inner Mongolia. Among patients with DM and HTN, the crude rates of fasting plasma glucose (FPG) treatment and control was 30.76% and 4.73%, respectively. Crude rates of BP treatment and control were 50.81% and 8.70%, respectively. The authors found that treatment rates of HTN and DM and control rates of BP and FPG showed a gradually increasing trend with increased age. Among patients with DM and HTN, the likelihood of treatment for HTN and DM was significantly increased among participants who were older, non-Mongolian, male, obese, smokers, and those with previous cardiovascular disease. The authors found that control of BP, FPG, and low-density lipoprotein cholesterol was far from optimal among study participants. Medical and health departments in Inner Mongolia should take appropriate measures to reduce the burden of DM and HTN in the population, such as by promoting and improving the quality of HTN and DM treatment to achieve control goals and reduce the risk of cardiovascular disease.

更新日期：2021-11-30

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南